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Abstract
Background: India’s economic growth rate in recent years has been fairly impressive. But, it has been consistently 
failing to make considerable progress in achieving health related Millennium Development Goal (MDG) targets. Lack 
of coherence between provisions and utilization becomes the face of the problem. Inadequacies in outreach, access 
and affordability coupled with escalating healthcare costs have aggravated the problem. Here the application of Public-
Private Partnership (PPP) model seems to have enormous potential to ease the impasse.
Methods: This paper tries to find the gap between the provisions and access in healthcare. The paper attempts 
to construct a Health Infrastructure Index (HII) and Health Attainment Index (HAI) for different states of India. 
Considering the presence of regional variations found in health infrastructure and attainment among the states, two 
states, viz. Maharashtra (MAH) and West Bengal (WB) have been chosen. Then contributions of health programs like 
Rashtriya Swasthya Bima Yojana (RSBY), National Rural Telemedicine Network (NRTN) and Fair Price Shops (FPS), 
all PPP initiatives, have been assessed for both the states by carrying out comprehensive benefit-cost analysis.
Results: The health infrastructure for population per unit area captures the outreach/delivery issue and the health 
attainment reveals the true scenario about how far the infrastructure has been accessed by the people; and the gap 
between the two, as the paper finds, is the root of the problem. The combined effect of RSBY and NRTN will leave both 
MAH and WB higher benefits in terms of  health attainment. The contributions of RSBY and NRTN have been assessed 
for both the states by carrying out comprehensive benefit-cost analysis. FPS comes up with immense benefits for WB. 
It is yet to be implemented in MAH. 
Conclusion: The outreach and access problems arising from deficiencies in infrastructure, human resources and 
financial ability are expected to be well-addressed by the spread of RSBY and NRTN jointly. The FPS mechanism under 
PPP initiative can be an effective tool in solving affordability problem by reducing the cost of treatment.
Keywords: Health Infrastructure, Health Attainment, Public-Private Partnership (PPP), Benefit-Cost Analysis
Copyright: © 2015 by Kerman University of Medical Sciences
Citation: Dutta S, Lahiri K. Is provision of healthcare sufficient to ensure better access? An exploration of the scope for 
public-private partnership in India. Int J Health Policy Manag. 2015;4(7):467–474. doi:10.15171/ijhpm.2015.77
*Correspondence to:
Sabitri Dutta  
Email: sabitri.d@gmail.com
Article History:
Received: 8 November 2014
Accepted: 1 April 2015
ePublished: 8 April 2015
Implications for policy makers
• Healthcare outreach/delivery and financing are the major bottlenecks in achieving the targets. Infrastructure does not necessarily ensure 
attainment unless the facilities reach the population who are in real need of this. Outreach and access to the health services have been identified 
as two major areas where the country lags. Lack of spread of the services to every remote corner of the country leads to the outreach problem; 
where the financial incapability of the general population to avail the required health facility is the origin of access problem. Moreover, the 
exorbitant prices of the medicines make the situation harder for ordinary people. Hence, building healthcare infrastructure and addressing 
healthcare financing issues are the calls of the hour.
• Public-Private Partnership (PPP) in the health sector can be an effective way out. Three policies viz. Rashtriya Swasthya Bima Yojana (RSBY), 
National Rural Telemedicine Network (NRTN) and Fair Price Shops (FPS) under PPP initiatives can be possible solutions.
• Combination of NRTN and RSBY can help overcome the outreach/delivery and healthcare financing constraints. A combined expansion of the 
two programmes has the potential to generate benefits which may not be possible in the absence of any one.
• The medicines can be supplied to the public at much cheaper rate through the FPS mechanism. Hence, it can address the affordability problem 
by reducing a major part of the cost of treatment. 
Implications for public
The programs under Public-Private Partnership (PPP) initiatives are likely to ensure better quality service at affordable price all over the country and 
the Millennium Development Goals (MDGs) related to health will no longer appear unreachable for an emerging country like India.
Key Messages 
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Background
The Millennium Development Goals (MDGs) put a special 
emphasis on health. Three out of eight goals are related to 
health. India has failed to achieve considerable progress in 
MDG targets in health indicators (1). The mortality rate for 
children under five years of age in India tends to be 50 per 
thousand birth by the end of 2015 against the MDG target 
of 42 per 1,000 live births. For maternal mortality ratio India 
is expected to fall short of the 2015 target by 26 points. India 
made a significant effort in reducing the incidences of HIV/
AIDS, Malaria, tuberculosis (TB), and other diseases (2). 
The gap between the targets and achievements of MDGs 
needs special attention on the part of the Government. The 
failure to achieve the targets indicates problems in any or all 
of provision, outreach, access and affordability. Percentage of 
Gross Domestic Product (GDP) in India spent on health is 
as large as 4% in 2012 (3). It is almost impossible to achieve 
the targets through the public sector expansion alone over a 
finite time frame. The only solution may lie in the adoption 
of Public-Private Partnership (PPP) as an institutional 
breakthrough in the health sector. The World Bank (2001) 
and the National Commission on Macroeconomics in Health 
(2005) advocated inclusion of the private sector in achieving 
health related goals and making both public and private 
sectors more accountable. The Tenth Five-Year Plan (2002–7) 
also stressed the need for private sector participation in the 
delivery of healthcare services. 
In Indian federal structure health is a subject of both centre 
and state. So adoption and implementation of any policy in 
this sector is likely to experience an inter-state variation. For 
a successful MDG achievement three aspects are crucial, viz. 
provision, utilization and attainment. Any mismatch among 
these may lead to failure of the entire system. This paper 
investigates the gap between the provisions and access and 
hence utilization and attainment of  healthcare services among 
the target population in India. For that purpose attempt has 
been made to construct a Health Infrastructure Index (HII) 
and Health Attainment Index (HAI) for different states of 
India. On the basis of these indices two states, Maharashtra 
(MAH) (a high performing state) and West Bengal (WB) (an 
average performer) have been selected. 
Utilization of healthcare facilities again depends on 
affordability and access to these services that involve the cost 
of care or Out-of-Pocket (OOP) expenditure of the patient. 
This cost could be both medical and non-medical in nature. 
The medical cost includes cost of medicine and other related 
expenses including that incurred due to hospitalization or 
for availing diagnostic facilities, and so on. Non-medical 
part includes travel to the place of treatment, loss of wage 
due to travelling etc. Effective strategy can be adopted in 
these cases through PPP initiatives. Though a large number 
of medicine shops or diagnostic centers are available, there 
is an absence of effective competition among them; a tacit 
collusion through implicit market sharing agreement is 
apparent. To break this market power the governments of 
different states of India have decided to go for open bidding 
where a part of the infrastructure support will be provided 
by public and private will supply medicines and implants at 
significantly below the Maximum Retail Price (MRP) level. 
The medicines can be supplied to the patients at a reduced 
cost through fair price mechanism and can be implemented 
through setting up Fair Price Shops (FPS) in the public 
hospitals. The cost of hospitalization treatment can be taken 
care of by Rashtriya Swasthya Bima Yojana1 (RSBY) program 
where for the household living below the poverty line the 
cost of hospitalization would be reimbursed even when the 
treatment is carried out in the private institutions. Similarly, 
the non-medical expenses can be addressed by the program of 
National Rural Telemedicine Network (NRTN). All of these 
three programs are implemented through PPP mechanism. 
The paper analyzes the spread and prospect of FPS, RSBY, and 
NRTN in two selected states to assess the outreach expansion 
through enhancement of e-connectivity and smoothening out 
of financial risks in terms of insurance coverage and provision 
of supply of medicine at reduced cost. In fact, spread of 
telemedicine network is believed to play an important 
catalytic role in eliminating the time and space constraints 
of healthcare delivery system. Cost saving by the consumer 
(patient) is expected to be very beneficial in terms of financial 
access (non-medical) apart from geographical barriers of the 
outreach problem of healthcare delivery. Again, the RSBY 
scheme is currently acting as a very good example of PPP in 
India, in both healthcare service delivery as well as healthcare 
financing in the form of affordable health insurance scheme. 
About 129 million poor people are currently registered 
with approximately 37 million households covered under 
the scheme. 
The rest of the paper is organized as follows: section 2 
(Programs) discusses three programs separately. The 
methodology of developing HII and HAI as well as method 
adopted to assess net benefit of NRTN, RSBY, and FPS 
programs are discussed in section 3 (Methods). Section 4 
(Data) provides details the available data sources in India at 
the state level; section 5 (Results) presents the main findings 
and elaborates the rationale behind selecting MAH and WB as 
two representative states. Section 6 (Discussion) discusses the 
results and reports the status of NRTN, RSBY, and FPS under 
PPP in the selected states. Section 7 (Conclusion) concludes 
the paper by highlighting major findings and indicating their 
health policy implications. 
Programs
Fair Price Shops (FPS)
The price monopoly of the drug manufacturers is broken in 
this system through PPP mechanism. The drugs are procured 
through tender and by pursuing doctors to prescribe by 
the generic name. These medicines are made available 
at fair price medicine shops located at the Government 
hospitals. Patients are made aware that generic medicines 
are of the same quality i.e. in identity, purity, strength and 
effectiveness as branded medicines. The basic purpose of 
the system is to make available quality medicines, surgical 
items, cardiac implants, anti-cancer drugs, prosthetic and 
orthopedic devices at a cheaper cost so that patients can get 
the best advantage. The space for the shops is provided by the 
Government hospitals and the private partners are selected 
through an open bid. The highest bidder in terms of discount 
given on the medicine is chosen. Both Generic and branded 
generic medicines are sold. It is thought to be useful in India 
where 65% of the population still lacks regular access to 
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essential medicines, with the rise in healthcare cost; over 23% 
of the sick do not seek treatment because they are not having 
enough money to spend (4). 
With programs like NRTN and RSBY, it is expected that there 
will be increased participation of the weaker section of the 
population in healthcare market due to increased connectivity 
through NRTN and increased financial support through 
RSBY. In both these cases, the support is not confined to the 
publicly owned resources (infrastructure, service and man-
power) alone; there is wide scope for PPP. 
Rashtriya Swasthya Bima Yojana (RSBY)
The RSBY scheme covers protection up to Rs. 30,000 on 
a floater basis as hospitalization benefits. Fixed rates have 
been determined for intervention packages and it covers pre-
existing conditions without any age bar. It covers up to five 
members per family including the head of the household, 
spouse and three dependants. The beneficiaries need to 
register to the scheme with minimal fees of Rs. 30 per family. 
The premium burden of the policies is shared by the Central 
and the State Governments in 75:25 ratios. Selection of the 
insurers is done through competitive bidding. Both private 
and public insurers are allowed to be involved in the scheme. 
Similarly both public and private healthcare institutions are 
eligible for empanelment under the scheme and are very 
strictly monitored.
National Rural Telemedicine Network (NRTN)
The NRTN covers three levels: Networking Primary Health 
Centers (PHCs) to District Hospitals (Level-I), District 
Hospitals to State/Super-specialty Hospitals (Level-II), 
interconnected State/Super-specialty Hospitals (Level-
III) and also mobile units connected to nearest PHCs and 
District Hospitals (Level-M), all connected through high 
bandwidth fiber optic/satellite connection. Medical opinions, 
consultation, diagnosis and surveillance are possible at a very 
cost effective and efficient manner through telemedicine 
network spread across the country.
Methods
This section discusses methodology developed for: (i) 
constructing different HIIs, (ii) HAI, and (iii) that to estimate 
potential (net) benefit generated by the selected out-reach 
programs.
Health Infrastructure Index (HII)
HIIs have been constructed by incorporating three different 
dimensions: (a) purely public health infrastructure related 
components like hospital beds for per 100,000 population, 
absolute number of government hospitals (including 
Community Health Centers and PHCs), number of doctors, 
nurse and pharmacists per hospital; (b) the hygiene related 
indicators like the source of drinking water and the types 
of latrine used by the households, and (c) the accessibility 
dimension captured in terms of availability of infrastructure 
per square kilometer of population (population density) to 
shed light on the congestion factor. Principal Component 
Analysis (PCA) has been used for determining the endogenous 
weights to combine this information, λj being the Eigen value 
for the jth factor (fj). HII_1 considers factors (a) and (b) 
whereas HII_2 considers all the three dimensions. 
_ , 1,2j j j
j j
HII i f iλ λ= =∑ ∑
Where,
fj: jth factor obtained from PCA
λj: eigen value for jth factor 
HII_i_final = (Actual _ HII _ i – Min _ HII _ i)/(Max_ HII_i – 
Min_ HII _ i)
Applying this formula on suitable data2 for both HII_1 
and HII_2, 3 factors have been extracted by PCA with 
the associated Eigen values exceeding unity3, and the 
indices explained 83% to 85% of total variation in health 
infrastructures across states. 
Health Attainment Index (HAI)
Three indicators have been selected to construct the HAI. 
The percentage of population completed the full course 
vaccinations (V); the percentage of  Non-Anemic (NA) persons 
and the mean Body Mass Index (BMI) for each state are the 
chosen set of variables. The health of an individual largely 
depends upon his/her resistance against the communicable 
diseases. So, in the analysis completion of vaccination is taken 
as an indicator of health attainment as it builds the required 
resistance against the communicable diseases. The incidence 
of anemia may again affect this resistance power. State 
wise percentage of population who are not suffering from 
anemia is considered as healthy and hence added in health 
achievement indicators of the state. In addition, a healthy 
person with resistance against diseases should always have 
a standard BMI which reflects the body physique and hence 
wellness of the person. The average BMI across the states 
is the third factor taken to form the HAI. National Family 
Health Survey-3 (NFHS-3) provides information on all these 
three variables. The BMI and NA data are given separately for 
males and females. A weighted average has been calculated 
for the variables with percentage of males and females in the 
total population of the state as the weights. First each of these 
variables has been normalized to bring them to same scale of 
variation. Finally simple average of V, NA and BMI is taken to 
construct the final HAI. As this have a huge range of values it 
has further been indexed as (Actual value-minimum value)/
(Maximum value-minimum value).
. _ . _ _
3
Avg BMI n Avg NA n V nHAI + += 
where
xk_n = (Actual _ xk – Min. _ xk)/(Max_ xk – Min._xk); k= 1, 
2, 3
x1: BMI, x2: NA, x3: V
Avgyp = (m*yp _ m+w*yp _w)/(m+w); p = 1, 2
m: % of males in total population
w: % of females in total population
yp _m: yp  for males
yp _w: yp  for females
y1: BMI, y2: NA
Benefit-cost estimation of selected out-reach targeted programs
NRTN: The National Telemedicine Task Force was set up 
by the Ministry of Health and Family Welfare, GoI, in 2005. 
Central and the different state governments are setting up 
telemedicine centers with technical guidance and assistance 
from Indian Space Research Organization (ISRO). Under 
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National Rural Health Mission (NRHM), telemedicine has 
the potential to expand service base to the remote places in 
absence of physical infrastructure. 
Cost: The cost of telemedicine network across the states 
consists of important components: (i) Cost of network 
connectivity, (ii) Fixed cost of installing computer set-up 
in the receiving stations, (iii) Fixed cost of medical devices, 
and (iv) Recurring cost of running the network. With the 
given number of PHCs, District Hospitals and State/Super 
Specialty Hospitals (facilities) per state the as well as given 
infrastructural requirements for these, let the fixed cost per 
capita be FCM for MAH and FCWB for WB. 
Total Fixed Cost for first level= FCl= No. of total facilities 
involved × unit fixed cost per facility
Total Recurring Cost for first level= RCl= No. of total facilities × 
unit recurring cost per facility
l=1,2,3,M
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where FCM: Fixed cost for NRTN in MAH,
FCWB: Fixed cost for NRTN in WB,
NC = Per capita cost for NRTN= At + RC; At= annualized per 
capita fixed cost for NRTN,
RC = recurring cost of NRTN per Capita.
Benefit: The per capita benefit from NRTN is calculated as 
the per capita OOP expenditure on non-medical expenses for 
healthcare including travel, food and other services related 
to treatment but not strictly related to illness for the Below 
Poverty Line (BPL) population.
NB = Per Capita Benefit for NRTN
Per Capita Net Benefit = (NB - NC)
RSBY: It was launched by the Ministry of Labour and 
Employment (GoI) in 2008 as a health insurance scheme 
for the BPL population of the country to provide financial 
assistance to the target group against huge OOP expenditure 
on health. The main objective of the scheme is to include 
the targeted population into the healthcare net by putting 
forward the much needed financial assistance through health 
insurance protection.
RC= Per capita cost for RSBY = (Premium per family/ No. of 
family members registered for RSBY)
RB= Per capita benefit for RSBY= (Amount of claims in rupees/
No. of claims)
RNB= Per capita net benefit= (RB - RC)
FPS: No specific methodology has been used for cost-benefit 
analysis of FPS in these two states. Only the reduced cost of 
medicines in the FPS is reported in comparison to the MRP to 
show the extent of potential benefit on the part of the patients. 
Data
For this study relevant data have been collected from several 
sources. The National Health Profile 2005 (5) published by 
the Central Bureau of Health Intelligence (CBHI), India 
provided information on indicators of health required for 
construction of the HII. CBHI mainly compile data collected 
through a system called Sample Registration System (SRS)4 
(6). The relevant information used in the study includes the 
number of hospitals, beds, doctors, nurses and pharmacists in 
28 states of India including Delhi5. It also uses hygiene related 
information like drinking water source and type of sanitation 
from National Sample Survey Organisation (NSSO) 60th 
round (2004) (7) household survey data6. The survey provides 
all household related information (like house type, structure, 
social group, religion, monthly expenditure of household, 
type of latrine, drainage, drinking water source, etc.) along 
with information on hospital access, reasons for not being 
treated, medical and non-medical expenses and on morbidity 
at the individual level: whether the individual is ailing over 
the last 15 days before the survey (yes/no type) or not7. 
HAI uses state wise data on percentage of population 
completed the full course of V, percentage of NA population 
and the average BMI. Information provided by NFHS-3, 
2005–6 (8) has been used for the analysis8. Population data 
has been taken from Census 2001 (9) where data is collected 
on complete enumeration basis. The ailments in this case are 
the self-reported morbidity by the informant9. 
The supply side data required for the analysis of telemedicine 
(NRTN Network) and provision of social health insurance 
(RSBY) have been collected from the relevant official websites 
as well as respective State Government sources and some 
demand side information has been extracted from NSSO 60th 
round household level data.
Results 
Comparative position of states in terms of Health Infrastructure 
Index (HII) and Health Attainment Index (HAI)
When the health infrastructure is represented in terms of 
availability of medical institutions, medical persons and 
provision related to hygiene and sanitation at per capita 
basis (HII_1) then the correspondence between HII and 
HAI is 0.61 with a high level of statistical significance. This 
endorses the popular policy orientation of creating better 
infrastructure to attain better health status. However, once 
the spread of this infrastructure across the state has been 
taken into consideration by expressing everything in terms 
of population density (population per square kilometer), the 
picture changes drastically. Now, the correlation between 
HII_2 and HAI is statistically insignificant indicating 
location-based concentration of health infrastructure. This 
observation leads us to the question that how the specifically 
targeted outreach programs are helping to even out this 
inherent bias in the provision of infrastructure and related 
amenity services? We have already selected three such 
program, viz. FPS, NRTN, and RSBY and now for in-depth 
investigation we will choose 2 states from the whole set of 28. 
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In Table 1 the values of HII_1, HII_2 and HAI are reported 
for 28 states of India. 
Maharashtra (MAH) viś-a- viś  West Bengal (WB): a comparative 
analysis
In terms of both HII_1 and HII_2, WB’s scores (25.74 and 
39.67) are marginally below the all India average scores (27.01 
and 39.71) whereas for MAH the corresponding scores are 
20.08 and 98.61 respectively, indicating a drastic change in 
the relative position in terms of inclusion of the out-reach 
dimension. While WB is representing an average state, MAH 
is extremely favorably placed in terms of uniform spread 
of health facilities over the entire state. In terms of health 
attainment, the value of HAI for MAH is 60.54 and that of 
WB is only 40.94. The all India average score is 52.27, which 
is closer to that of MAH. Though in terms of both HII_1 
and HII_2, WB is pretty close to all India score, in terms of 
attainment it is lagging far behind. So, access to provision 
is appeared to be a weak point for WB and strong point for 
MAH. It would be interesting to compare the performance 
of FPS, NRTN, and RSBY programs in these two states to see 
how they are deriving benefits from these specifically targeted 
out-reach expansion programs in the health sector.
Program evaluation
Benefit and cost (RSBY): RSBY scheme has the potential to 
expand the healthcare base for the BPL population. Average 
premium of RSBY per family comes to Rs. 372 for MAH and 
Rs. 346 for WB (Table 2 fourth block). With an average of 3.5 
members per family registered for RSBY (10), the per capita 
cost comes to Rs. 106 for MAH and Rs. 99 for WB. Again, the 
value per claim can be regarded as the benefit that accrues to 
the consumers (patients). This comes out to be Rs. 4,817 per 
capita for MAH and Rs. 5,941 per capita for WB. Thus the 
net benefit of RSBY comes to Rs. (4,817–106)= Rs. 4,711 for 
the former and Rs. (5,941–99)= Rs. 5,842 per capita for the 
latter. After suitable price adjustment this comes to Rs. 3,780 
for MAH and Rs. 4,711 for WB at 2008–9 prices.
Benefit and Cost (NRTN): The OOP expenditure on non-
medical expenses for healthcare including travel, food and 
other services related to treatment but not strictly related to 
illness for the BPL population approximately comes out to be 
Rs. 400 for MAH and Rs. 330 for WB (Table 2). After suitable 
price adjustment it comes to Rs. 524 for MAH and Rs. 432 
for WB at 2009 prices. With free NRTN services envisaged 
by the Government, the entire amount accrues as benefit to 
the people. 
Since the population density of  WB (904/ km2) is much higher 
than that of MAH (314/ mk2) the fixed cost per capita is equal 
to Rs. 61 for MAH and Rs. 35 for WB while the recurring cost 
per capita is estimated to be Rs. 24 and Rs. 14 for the states 
respectively. The fixed investment is expected to depreciate 
over a period of 5 years after which it would be required to 
get replaced. So, the annualized value (At) with an interest 
rate of 15% would come up to Rs. 14 for MAH and Rs. 8 for 
WB. Thus, the per capita total cost of NRTN becomes Rs. 38 
(fixed cost + recurring cost) for MAH and Rs. 22 for WB. The 
annual cost of accessing the service of HealthSAT, a dedicate 
satellite for telemedicine related networking comes out to be 
approximately equal to Rs. 1.1 billion (11). This is expected 
to provide service to 802 million rural people with a per 
capita cost of Rs. 1.5 (approximately) (12). After suitable price 
adjustment it comes to Rs. 1.75 approximately. This added to 
the total cost amounts to Rs. 40 per head for MAH and Rs. 24 
per head for WB.
The net benefit will be Rs. (524–40)= Rs. 484 for MAH and 
Rs. (432–24)= Rs. 408 for WB. According to NSS data the 
reported morbidity of the BPL population is 14.50% in MAH 
and 15% in WB. With spread of telemedicine a 10% increase 
in reported morbidity would generate a net benefit of Rs. 2.15 
billion for MAH and Rs. 1.82 billion for WB.
FPS: No cost-benefit analysis has been carried out as such 
for FPS. The difference in the price of the medicines in open 
market shops and that in the FPS where the medicines are 
sold in generic name is shown in Table 3. Benefits from the 
system have been tried to be made out from this information. 
On the part of the Government the entire system requires 
only space for opening FPS. As this space is already there 
in the Government hospitals and does not require any 
additional infrastructure, marginal cost for the program, on 
the side of the Government, is effectively zero. In the private 
front, the cost of advertisement for any particular brand gets 
Table 1. HII by states of Indiaa
Sl. No. State Population density HII_1 HII_2 HAI Sl.  No. State Population density HII_1 HII_2 HAI
1 AP 275 21.73 54.67 46.35 15 MP 196 11.56 47.21 31.07
2 ARP 13 40.76 58.91 44.42 16 MAH 314 20.08 98.61 60.54
3 ASM 340 12.42 26.01 15.49 17 MNP 107 22.23 19.18 72.86
4 BHR 880 5.36 32.63 17.46 18 MEG 103 22.99 26.03 44.38
5 CHGH 154 3.89 37.35 32.29 19 MIZ 42 26.23 15.07 68.31
6 DEL 9294 99.89 43.14 88.07 20 ODI 236 4.70 40.66 30.60
7 GOA 363 82.27 33.30 88.55 21 PUN 482 31.95 37.22 91.95
8 GUJ 258 24.86 54.49 47.37 22 RAJ 165 15.82 63.99 30.85
9 HAR 477 23.17 36.14 61.77 23 SIK 76 45.03 1.34 72.71
10 HP 109 24.79 45.66 70.20 24 TN 478 25.61 48.13 77.89
11 JK 99 25.10 42.19 64.46 25 TRI 304 32.55 26.21 26.77
12 JKND 338 1.02 26.60 0.05 26 UP 689 4.16 36.65 31.27
13 KAR 275 24.35 58.80 55.42 27 UTRK 159 53.71 41.40 51.47
14 KER 879 24.26 20.50 99.95 28 WB 904 25.74 39.67 40.94
HII= Health Infrastructure Index; HAI= Health Attainment Index.
aAll India Average: HII_1= 27.01, HII_2= 39.71, HAI= 52.27; Corr (HII_1, HAI)= 0.61 (significant), Corr (HII_2, HAI)= 0.07 (insignificant).
Source: Authors’ calculation.
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reduced. This is because in such shops drugs sold are either 
generic or branded generic. In case of generic without brand, 
the advertisement cost of the manufacturer is absent. In 
case of branded generic a group of medicines (with different 
generic name) are sold under the same brand umbrella. So 
advertisement for drugs with different names sold under 
a particular brand is not needed, only brand advertisement 
is sufficient. This indicates that the marginal cost of such 
program is very low whereas the benefit is huge. Benefits 
outweigh cost and therefore it is worth implementing. The 
FPS under PPP has already started in WB. It has launched Fair 
Price Medicine shops in the secondary and tertiary hospitals 
in the state. No such specific attempt has so far been noticed 
in MAH. 
Discussion 
As mentioned earlier our choice of study remains restricted to 
MAH and WB. In Table 2, we briefly report the demography 
and infrastructural availability related to healthcare for WB 
and MAH. The availability of private infrastructure (in terms 
of hospitals alone) is, in manifold, larger in both MAH and 
WB compared to the public network alone (as mentioned 
in Table 2 first block). Therefore PPP could be the strategic 
instrument to expand outreach at an affordable price.
Clearly, from Table 2 MAH is ahead of, WB in terms of, 
absolute number of available infrastructure. Fifteen percent 
of BPL population in WB and 14.50% of BPL population in 
MAH is morbid with approximately 9% and 6.50% of them 
in WB and MAH not receiving any treatment. Interestingly, 
among those who have availed the treatment the morbidity 
percentages of the BPL category are lower than the average 
morbidity rates of the two states. This reveals the fact 
that healthcare services remain out of the reach of a high 
percentage of the BPL population, keeping in mind the fact 
that data reflects reported morbidity only. Among the major 
reasons of not getting treated are lack of facilities and financial 
reasons. This conforms to the infrastructural deficiencies and 
financial inabilities to meet healthcare demand. Moreover, 
high OOP expenditures, both for non-medical and medical 
purposes for healthcare keep high percentage of population, 
who actually need it, out of the healthcare market. Study 
by Chatterjee (18) revealed that the perceived need for 
healthcare culminates from actual need, availability, ability 
and affordability. This raises the issue of social justice 
regarding availability and affordability of healthcare of the 
population in need. With greater overall access to public 
healthcare facilities in WB (72.28%) than in MAH (28.33%), 
the average expenditure for healthcare is lower in WB than in 
MAH. Expansion of telemedicine services through the NRTN 
would enable the remotely located people to avail healthcare 
services within their region without outbound travel saving 
travel cost as well as time. NSSO 60th round survey database 
on ‘Morbidity and Health Care’ data reveals that the high 
percentage of not availing any medical attention arises from: 
(i) absence of facility within reach, (ii) long waiting time, (iii) 
lack of fund to finance healthcare related services, and (iv) 
Table 2. Estimation of per capita net benefit from NRTN and RSBY programs
Demography1 MAH WB Public hospital2 MAH WB Treatment availed3 MAH WB
Population 97 mn 80 mn Primary 1,809 909 Morbidity (%) 20 20
BPL (%) 25 27 Secondary 23 15 Morbidity (BPL) % 14.50 15
Area (km2) 308 K 89 K Tertiary 897 291 In public hospital 28 72
Population density 314 904 Private hospital4 3,023 2,013 In private hospital 72 28
Untreated BPL5 Treatment not availed (BPL)6 Average expenditure incurred (BPL)a
Morbidity (%) 15 15 No facility (%) 25 14 Medical (Rs.) 3,476 2,009
Without treatment (%) 7 9 No money (%) 33 36 Non-medical (Rs.) 400 330
NRTNb (Cost and net Benefit)7
Level-I (Rs. mn) 5,018 2,901 Level-III (Rs. mn) 4,132 1,341 Total cost (Rs. mn) 9,492 4,465
Level-II (Rs. mn) 147 96 Level-M (Rs. mn) 195 127 Per capita Cost (Rs.) 85 49
Per capita fixed cost (Rs.) 61 35 Per capita recurring cost (Rs.) 24 14 Per capita net benefit (Rs.) 484 408
RSBYc (cost and net benefit)8 
Enrolment Claims Receipt & Payment
Family 510,753 5,368,404 Count 59,478 526,898 Premium/ policy (Rs.) 372  346 
Individual 1,787,636 18,252,574 Disbursed  (Rs. mn) 286.50 3,130.20 Receipt/ policy (Rs.) 4,817 5,941
Per capita cost (Rs.)  106  99 Per capita gross benefit (Rs.) 4,817 5,941 Per capita Net Benfit (Rs.)  780  4,711 
NRTN= National Rural Telemedicine Network; RSBY= Rashtriya Swasthya Bima Yojana; BPL= Below Poverty Line; MAH= Maharashtra; WB= West Bengal.
a Monetary values in 2008–9 prices. b Monetary values in 2006–7 prices. c Monetary values for MAH in 2011-2 prices and for WB in 2013–4 prices.
Source: Authors’ calculation by collating information from different sources; 1: (9) 2001; 2: Official sites of the respective state governments; 3, 5, 6 (7,13, 
14);  4: (15); 7: (16); 8: (10).  
Table 3. Drug price comparison: generic name versus brand name
Disease/use generic/name 
of drug 
Generic name of drug Pack size 
Generic drug tender 
Price (Rs.)
Equivalent popular brand 
MRP of Branded  
Medicine 
Pain killer Diclofenac sodium tablets IP 50 mg 10 tab strip Rs. 1.24 Voveran (Novartis) Rs. 31.73
Cholesterol lowering drug Atorvastatin tablets IP  10 mg 10 tab blister Rs. 2.98 Atrova (Zydus) Rs. 103.74
Heart diseases Clopidogrel tablets IP 75 mg 14 tab strip Rs. 8.54 Plavix (Sanofi) Rs. 1,615.68
Diabetes Glimepiride tablets  IP 2 mg 10 tab strip Rs. 1.95 Amaryl (Aventis) Rs. 117.40
MRP= Maximum Retail Price.
Source: Reference 17.
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not considering the ailment serious enough to be reported. 
It is expected that reported morbidity rates for the BPL 
population would be higher and the left out population will 
have enough incentive to avail the benefits of healthcare with 
available NRTN coupled with financial access through RSBY, 
thus the gap, even between reported morbidity rate through 
NSSO and RSBY would lessen.
From Table 2 it is evident that WB is way ahead of MAH 
in terms of RSBY coverage. It is expected that the target 
population will soon be reached in both the states to cover the 
entire BPL population. WB has now got a dedicated website for 
RSBY unlike MAH. An important fact is revealed from Table 
2. The ratio of number of claims to the number of individuals 
registered for RSBY reflects the morbidity scenario among 
the BPL population. It reflects that only 2.88% of the BPL 
population is morbid, according to WB data. This is in sharp 
contrast to what we find in Table 2 (15%). Since WB is a state 
where RSBY has reached a fair amount of coverage, this gap 
reflects the non availability of infrastructure for the deserving 
population, especially in the remote rural areas. Moreover, 
high OOP expenditure related to non-medical expenses for 
healthcare, not covered by RSBY still deters a high percentage 
of population in need from availing the healthcare services. 
In face of reduced public share of healthcare facilities, it is 
evident that without a prepared market the private sector 
participation would not be ensured in remote rural areas. A 
matured insurance market such as RSBY could have catalytic 
effect in preparing rural markets for healthcare.
Table 2 also produces a net benefit of Rs. 4,711 for WB and 
RS. 3,780 for MAH at 2009 prices. Moreover, with Rs. 382.82 
being the per capita per month poverty line for WB (2004) 
and Rs. 362.25 the per capita per month poverty line for MAH 
(2004), the annual value of per capita BPL incomes becomes 
Rs. 5,400 for WB and Rs. 5,100 for MAH after suitable price 
adjustment. Rs. 30,000 potential coverage per year for implies 
a 555% of annual income coverage for BPL population of 
WB and 588% of annual income of BPL population for 
MAH. As per RSBY coverage of 3.5 persons per family (10), 
if we calculate with two earning members per family with 
1.5 dependant members, the annual income per family per 
year is expected to be Rs. 10,800 for WB and Rs. 10,200 for 
MAH. With Rs. 30,000 floating coverage of RSBY, it covers 
278% of the annual income of BPL families in WB and 294% 
of the BPL families in MAH. With morbidity coming as a 
shock and the treatment part leading to disastrous outcomes 
in terms of burden leading to medical poverty trap for most 
of the deserving population. With high potential coverage 
as proportion of annual income, the potential benefit is very 
high even if family is taken as unit. This coverage in turns 
protects the families from the potential medical poverty 
trap. Considering a combined effect of RSBY and NRTN, the 
expected net benefit per capita comes to Rs. 5,186 for MAH 
and Rs. 5,110 for WB for the deserving population. Thus a 
10% more spread of the duo would result in Rs. 22.58 billion 
for MAH and Rs. 22.63 billion for WB for the deserving BPL 
population alone which is approximately 0.24% and 0.52% 
of the gross State Domestic Product (SDP) of the respective 
states. Since NRTN network is for all, the resultant benefit is 
expected to be more than as estimated. Population density 
being higher in WB and MAH being spread across larger 
area, the benefits of telemedicine would expectedly serve 
MAH more. Though MAH is one of the better performers in 
India in terms of health infrastructure and health attainment 
indices and WB is an average performer in these respect, 
both States will be in a position to benefit largely from the 
expansion of RSBY as well as NRTN projects
Medicines take the major share in treatment cost. Drugs 
are different from other consumer items. So the free market 
economy and the price competition cannot make the prices 
lower for them. Branding in drugs creates artificial monopoly 
and drug manufacturers are able to keep the MRP higher 
in spite of presence of competitors in the market. The need 
for the drugs is always urgent. Consumers of drugs are 
vulnerable. The branding and high MRP make the situation 
worse especially for those who come from poor economic 
background. Table 3 compares the price of some common life 
saving medicines when sold in generic name and in branded 
pack. The difference is enormous as revealed from the table. 
If the drugs are sold through FPS in generic name it would be 
of immense benefit for the people who avail public healthcare 
services. The mechanism has been extremely successful in 
WB. The OOP expenditure of the patient for treatment is 
6.15% of the average annual SDP of the state out of which 66% 
is spent on medicines only (19). FPS was introduced in the state 
in the end of 2012. The present scenario says, as mentioned in 
the article, that the patients who are admitted in the hospitals 
are getting more medicines free of cost, Government doctors 
are prescribing 60% generic drugs on an average and most 
importantly the cost of treatment for medicines has reduced. 
Since end of 2012, 93 stores have become operational selling 
medicines at a discount ranging from 47% to 67% of the MRP 
quoted in the open market to all customers. The data provided 
by the state health ministry shows that for 35 FPS, during 
December 2012 to November 2014, total discount availed by 
the people is as large as 250 crores that have benefited 85 lakh 
persons (20). This puts enough evidences that FPS under PPP 
can be one of the solutions to the problem of affordability for 
the healthcare services. The example of  WB can be an instance 
for other states including MAH which has not adopted any 
such policy so far. 
Conclusion
Health is the key issue in the MDGs set for the countries 
globally. In spite of having a dramatic economic growth rate 
and food surplus India has failed to make significant progress 
in achieving the MDG targets. Infrastructure does not 
necessarily ensure attainment unless the facilities reach the 
population who are in real need of this. Outreach, affordability 
and access to the health services have been identified as the 
major areas where the country lags. The health infrastructure 
for population per square kilometer captures the outreach/
delivery issue and the health attainment reveals the true 
scenario about how far the infrastructure has been accessed 
by the people; and the gap between the two, as the paper finds, 
is the root of the problem. On the basis of infrastructure and 
attainment indices two states have been chosen for the further 
analysis. MAH, being a better performer in both, has been 
selected as an above average state; WB is chosen as an average/
below average state in terms of the indices mentioned. Lack of 
spread of the services to every remote corner of the country 
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leads to the outreach problem; where the financial incapability 
of the general population to avail the required health facility 
is the origin of access problem. Solution is hardly possible 
using only the public resource. A joint initiative from public 
and private both may work well. PPP in health is therefore 
an efficient way out. NRTN, RSBY, and FPS under PPP come 
extremely effective when used together in a combination. A 
combined expansion of the three schemes will generate the 
estimated benefits which may not be possible without any 
of the three. Separately the outcome may be lower rate of 
morbidity reporting as found for RSBY in WB. Thus under 
the combined influence of these three social programs, the 
outreach and access problems of healthcare delivery system in 
India can be tackled. PPP becomes the most crucial and useful 
instrument for a successful implementation of the programs. 
With the present pace of progress a convergence between WB 
and MAH is expected in next few years. The validation of the 
hypothesis is possible when more updated data in the relevant 
field would be available. Programs undertaken under PPP 
schemes are likely to lead to better equity prospects and social 
justice for the population under the aegis of globalization and 
privatization especially for a conceptually changing good like 
healthcare.
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Endnotes
1. RSBY: Rashtriya (National) Swasthya (Health) Bima (Insurance) Yojana 
(Plan).
2. Section 3 discusses the data sources.
3. For HII_1 the Eigen values are (2.36, 1.50, 1.12) and for HII_2 the Eigen 
values are (2.67, 1.25, 1.15).
4. The sample design adopted for SRS is a uni-stage stratified simple random 
sample without replacement. 
5. The administrative status of Delhi has been changed from Union Territory  to 
State in 1993. 
6. NSSO collects data from all Indian states and union territories through 
stratified random sampling technique.
7. It has been established by NSSO through several experiments carried out on 
optimal recall period that for temporary indisposition recall is most reliable over 
last 15 days only. The remote memory of any temporary ailment is not retained 
over a longer period barring the exception of hospitalization episode. So, here 
for hospitalization episode the reference period has been taken as 1 year and 
for other ailments, last 15 days.
8. NFHS-3 uses two-stage sampling design for villages and three-stage 
sampling design for urban areas. The design is based on probability proportional 
to population size (PPS) method, stratification and systematic sampling method.
9. It may be noted that some ailments may be treated (either as an inpatient of 
a hospital or otherwise) and some untreated – both the cases are considered 
here. A person under medication for an ailment during the reference period, 
whether he/she felt sick or not, is treated as ailing; cases of complications 
arising during pregnancy or after childbirth are considered as ailment; untreated 
injuries like cuts, burns, scald, bruise etc. of minor nature are not considered 
unless the informant considered them to be severe enough.
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